Inside the Journals: How Independent National Monitoring Can Drive WHO Resolution Implementation on SLD

Nov 05 2026
Convention Center: Summit 2, The Park @TLM, Hall D
2:30 PM - 3:00 PM

Description

The WHO approved the Assembly’s first ever resolution on steatotic liver disease on May 22, 2026. How can independent national monitoring drive implementation? Come discuss with Dr. Lazarus, an author of the recent HEPATAOLOGY commentary “AASLD’s opportunity to lead national monitoring of the World Health Assembly resolution on steatotic liver disease.” Read the article here: https://doi.org/10.1097/HEP.0000000000001861.
 

Presentations

2:30 PM - 2:40 PM
Convention Center - Summit 2, The Park @TLM, Hall D

Presentation

Jeffrey V Lazarus, PhD | Presenter
2:40 PM - 3:00 PM
Convention Center - Summit 2, The Park @TLM, Hall D

Audience Q&A and Discussion

Jeffrey V Lazarus, PhD | Moderator